Rezzayo Injection, Powder, Lyophilized, For Solution
Product Images NDC 70842-240

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rezzayo (NDC 70842-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Melinta Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Carton (package principal panel)

This is a description of a medication called Rezafungin for injection. It is supplied in a single-dose vial containing 200 g of Rezafungin acetate, with instructions for intravenous infusion only. The vial must be reconstituted and further diluted prior to use, and any unused portion should be discarded.*

FDA Label Image

Image Of Chemicalstructure (Fig 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.